Barclays’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-95,700
Closed -$3.82M – 4862
2020
Q3
$3.82M Buy
95,700
+92,700
+3,090% +$3.93M ﹤0.01% 1585
2020
Q2
$135K Hold
3,000
– – ﹤0.01% 4336
2020
Q1
$101K Buy
+3,000
New +$108K ﹤0.01% 4785

Other funds holding ATRC

Barclays's ATRC Position: Q3 2026 in Review

Barclays increased its AtriCure (ATRC) stake by 31% in Q3 2026, buying an estimated $387K and bringing the position to 36,172 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Barclays first reported a position in ATRC in Q2 2013 and has held it in 54 quarters since. The position peaked at $7.44M in Q1 2020. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Barclays held 36,172 shares of AtriCure worth $2.03M as of Q3 2026.
  • Barclays bought 8,590 AtriCure shares in Q3 2026, an estimated $387K.
  • AtriCure made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2577 holding.
  • Barclays first reported a position in AtriCure in Q2 2013 and has held it in 54 quarters since.
  • Barclays's AtriCure position peaked at $7.44M in Q1 2020.
  • 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.